Dendreon Revenue

Biotechnology Research • Seal Beach, California, United States • 501-1000 Employees

Dendreon revenue & valuation

Annual revenue	$312,000,000
Revenue per employee	$501,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$998,400,000
Total funding	No funding

Key Contacts at Dendreon

Jon Deleon

Regional Sales Director, Central U.S. Uro / Oncology

Patrick Stinson

Corporate Account Director-Southeast

Margaret Warner-Lubin

Director Clinical Operations

Monica Forshey

Regional Sales Director—East

Drew Saelens

Director, Government Affairs And Advocacy

Charles C. Miraglia

Medical Director, Apheresis

Danielle Behrens

Director, Communications And Marketing

Randy Pratt

Urology / Oncology Regional Sales Director At Dendreon

Joseph Sacchetti

Director National Pe/Mso Accounts, Oncology/Urology

Helen Fong

Interim Director Of Human Resources

Company overview

Headquarters	1700 Saturn Way, Seal Beach , CA 90740, US
Phone number	+18772564545
Website	dendreon.com
NAICS	541714
SIC	283
Keywords	Urology, CMO, Contract Manufacturing, Oncology, Cancer Treatment, Immunotherapy, Cellular Immunotherapy
Founded	1992
Employees	501-1000
Socials

Dendreon Email Formats

Dendreon uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@dendreon.com), used 39.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@dendreon.com	39.6%
{first initial}{last name}	jdoe@dendreon.com	31.2%
{first initial}.{last name}	j.doe@dendreon.com	23.2%
{last name}{last name}	doedoe@dendreon.com	3.2%
{first name}{last name}	johndoe@dendreon.com	2.4%

About Dendreon

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.

Employees by Management Level

Total employees: 501-1000

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Dendreon has 273 employees across 15 departments.

Departments

Number of employees

Funding Data

Dendreon has never raised funding before.

Dendreon Tech Stack

Discover the technologies and tools that power Dendreon's digital infrastructure, from frameworks to analytics platforms.

Autoptimize

Performance

reCAPTCHA

Security

Gravity Forms

Form builders

Microsoft 365

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Salesforce

CRM

Google Tag Manager

Tag managers

Frequently asked questions

Dendreon is located in Seal Beach, California, US.

You can reach Dendreon at +18772564545.

Dendreon generates an estimated annual revenue of $312,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Dendreon has an estimated valuation of $998,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Dendreon was founded in 1992, making it 34 years old. The company has established itself as a significant player in its industry over this time.

Dendreon has approximately 501-1000 employees. The company continues to grow its workforce to support its business operations and expansion.